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E-cadherin expression in the kidney is used as a surrogate
marker of epithelial mesenchymal transition for the testing of
various antifibrotic strategies. Here we reexamined
E-cadherin expression in the kidneys of rats with unilateral
ureteric obstruction, which was previously reported to
decrease in parallel with the development of
tubulointerstitial disease in this widely used experimental
model of renal fibrosis and epithelial mesenchymal
transition. E-cadherin mRNA expression was consistently
increased both acutely (hours) and chronically (days) in the
ligated kidney compared to the cognate non-ligated kidney.
Increased E-cadherin protein levels were also found in the
ligated kidney particularly in dilated tubular segments.
Simulation of early pressure changes in the ligated kidney by
mechanical stretch of human renal epithelial cells in culture
did not alter E-cadherin expression. Porcine LLCPK-1 cells
subjected to hypotonic stretch, however, did have increased
E-cadherin mRNA and protein levels, responses that were not
prevented by transforming growth factor-b, a cytokine that
promotes epithelial mesenchymal transition. Our findings
question the utility of E-cadherin as a marker of epithelial
mesenchymal transition in this model of renal fibrosis.
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Unilateral ureteric obstruction (UUO) causes rapid develop-
ment of renal tubulointerstitial fibrosis, (reviewed in
Bascands and Schanstra and Docherty et al.1,2). Transforming
growth factor (TGF)-b1 is a key fibrotic mediator in
obstructive (originally observation Diamond et al.3) and
nonobstructive nephropathies.4
Epithelial mesenchymal transition (EMT) has been
implicated in embryogenesis, malignancy, and fibrosis. Renal
tubular EMT is proposed to contribute to fibrosis, with TGF-
b1 acting as a major mediator of this process.5 A current
PubMed search using ‘EMT AND renal AND fibrosis’ reveals
94 references since 1997.
The early loss of the adherens junction protein E-cadherin
is commonly used to characterize the presence of EMT. A
current PubMed search using ‘EMT AND renal AND fibrosis
AND E-cadherin’ finds 40 articles.
This phenomenon has been proposed to occur in the
UUO model, the strongest argument for which was put
forward by Iwano et al.6 that claimed to demonstrate that
36% of activated fibroblasts in the UUO model were derived
from the proximal tubular epithelium. Preservation of E-
cadherin expression in the obstructed kidney has been cited
as evidence of an inhibition of EMT in Smad3 and
plasminogen null mice that are protected from UUO-
induced tubulointerstitial fibrosis.7,8 Renal E-cadherin ex-
pression has also been used as a surrogate marker of EMT on
which to test the efficacy of novel antifibrotic strategies (for
example, erythropoietin, paracalcitol, geranylgeranylacetone,
and irbesartan8–12).
Two interesting recent studies contest a role for
EMT in renal fibrosis, first by suggesting that fibroblast-
specific protein-1 can be expressed by inflammatory
cells in renal injury.13 Specifically in the UUO model,
using light and electron microscopy analyses and
immunohistochemistry, Picard et al.14 claim that interstitial
fiber-producing cells in UUO are derived from resident
fibroblasts, and provide no evidence supportive of
EMT.
In light of these studies and having previously examined
E-cadherin loss during EMT in the HK-2 cell line,15 we were
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interested per se in using E-cadherin loss as a marker of EMT
in UUO.
RESULTS
Distal tubular dilatation, inflammation, and the development
of tubulointerstitial fibrosis in the L kidney
We quantified distal tubular dilatation at 24 h, 3 and 10 days
post-UUO, as a pathological sequela of urinary pooling.
Mean distal tubular luminal area (mM2) was not changed at
any time point in non-ligated (NL) kidneys (24 h NL
(521.5±100.7) versus 3-day NL (572.4±33.4) versus 10-
day NL (672.9±153.3)). Areas were increased significantly in
the ligated (L) kidney as a function of time post-obstruction
(24 h L (1048.2±124.5) versus 3-day L (2051.2±146.8,
P¼ 0.007) and 3-day L (2051.2±146.8 versus 10-day L
(3138.4±161.8, P¼ 0.008; Figure 1).
Non-ligated kidneys at 24 h, 3 and 10 days post-UUO
showed a normal morphology (Figure 2a and b). L kidneys at
3 and 10 days post-UUO showed tubular dilatation with an
expanded interstitium containing a predominantly lympho-
cytic infiltrate (Figure 2c and d).
At 10 days post-UUO, the L kidneys of rats showed
evidence of mature collagen fibril deposition in the
tubulointerstitium (Figure 2e arrow). Hsp47 induction
provided molecular evidence of the fibrotic response
(Figure 2f).
E-cadherin mRNA is consistently increased in the L kidney
versus the NL kidney of rats following UUO
E-cadherin mRNA levels were not significantly altered in the
NL kidney at time points between 3 h and 14 days post-UUO.
Relative E-cadherin mRNA levels in L kidneys were calibrated
against 3h NL values revealing a 1.7±0.38-, 2.5±0.92-,
2.43±0.5-, and 2.56±0.61-fold increase in L kidneys at 3 h,
6 h, 3 and 10 days, respectively (all Po0.001), No significant
difference was observed in terms of degree of fold change
between L kidneys (Figure 3).
Induction of E-cadherin mRNA in L kidneys coincides with
increased protein expression
Densitometric quantification of western blotting signals for
E-cadherin following 3 and 10 days of UUO demonstrated a
twofold increase in full-length E-cadherin in L kidneys
(P¼ 0.05, 3-day NL versus L and P¼ 0.02, 10-day NL versus
L; Figure 4a and b).
Prolonged exposure of E-cadherin Western blots revealed
the presence of a small, approximately 30 kDa C-terminal
fragment and a longer 100 kDa C-terminal fragment in the L
kidneys of rats (Figure 4b).
Immunohistochemical localization of E-cadherin following
UUO
In the NL kidneys at both days 3 and 10, cortical staining was
at the basolateral aspect of the distal tubule (Figure 5a and c).
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Figure 1 | L kidney distal tubular luminal area increases with
time following UUO. H&E stained coronal sections of 24 h, 3 and
10-day NL and L kidneys were viewed at  20 in Image Scope
(Aperio) and distal tubular area in transverse section quantified.
The mean area in mM2 of 10 distal tubular segments per sample
was calculated and group means derived. n¼ 3 per sample,
*Po0.05 24 h NL versus L, #Po0.01 3-day L versus 3-day NL and
24 h L, and &Po0.01 10-day L versus 10-day NL, 3-day L, and
24 h L.
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Figure 2 | Inflammatory infiltration and tubulointerstitial
fibrosis in the post-UUO rat kidney. (a–d) Representative
hematoxylin and eosin stained 4 mm coronal sections of rat renal
cortex at 3 days post-UUO ( 20). (i) 3-day NL (ii) 10-day NL (iii) 3-
day L, and (iv) 10-day L. L kidneys at both time-points present
with tubular dilatation, lymphocytic infiltrate, and
tubulointerstitial expansion. (e and f) (i) Gomorri’s trichrome
staining of a 10-day L rat kidney ( 40) illustrating mature
collagen fibrils present in the expanded tubulointerstitium (arrow)
Images in a and b are representative of n¼ 3 per sample type (ii)
western blotting analysis of Hsp47 protein expression in paired NL
and L kidneys at 3 and 10 days post-UUO, demonstrating Hsp47
induction in the L kidneys n¼ 3 per group.
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Medullary staining was found in thick ascending limb and
collecting tubule (Figure 5b and d). In L kidneys, at both 3
and 10 days, there was strong immunostaining for E-cadherin
evident in lateral cell contacts of the dilated distal tubule, and
thick ascending limb and collecting duct segments sur-
rounded by areas of inflamed/fibrotic interstitium.
Mechanical deformation at pressures relevant to acute stages
of UUO do not alter E-cadherin or TGF-b1 mRNA expression
in RHPTEC
We investigated whether E-cadherin mRNA upregulation in
our model might be replicated in vitro with the single insult
of mechanical stretch. Exposure of confluent renal human
proximal tubular epithelial cells (RHPTEC) monolayers to
increased pressures did not alter E-cadherin expression
(mean CT values non-stretch, 10.7±0.28; physiological
Stretch, 10.77±0.27; and pathological stretch, 10.68±0.05).
Likewise results for TGF-b1 mRNA were 12.38±0.35,
11.97±0.15, and 11.98±0.34; Figure 6).
Interestingly, and in contrast to E-cadherin expression, we
did not observe alterations in TGF-b1 mRNA expression in L
kidneys at 3 or 6 h post-UUO relative to 3 h NL (fold
comparisons 1.45±0.52 and 1.45±0.49, respectively).
Hypotonic stretch induces increases in E-cadherin expression
in LLCPK-1 cells and is unaffected by TGF-b1
Incubation of cells in a hypotonic environment causes
activation of the stretch/swelling response initially character-
ized by the activation of stretch and swelling cation channels
with subsequent adaptation to restore cellular homeostasis.16
We tested hypotonic challenge as a reliable in vitro
activator of mechanical stretch stimulus transfer to tubular
cells. Hypotonic (HYPO) medium induced a significant 2.69-
fold increase in E-cadherin mRNA versus control (CTRL;
P¼ 0.02) whereas there was no significant difference between
control (CTRL) and ISO groups (Figure 7a). This result was
recapitulated at the protein level (CTRL versus HYPO,
P¼ 0.03; Figure 7b and c).
TGF-b1 does not affect the induction of E-cadherin
expression in LLCPK-1 cells
We coincubated hypotonic LLCPK-1 cells with TGF-b1 to
examine whether this had any effect on the induction of E-
cadherin. TGF-b1 was functional in inducing a profibrotic
response in LLCPK-1, as a dose of 3 ng/ml of TGF-b1 caused
a 2.8-fold increase in connective tissue growth factor (CTGF)
expression (P¼ 0.016). Hypotonicity caused a significant 5.8-
fold increase in CTGF expression (Po0.001), confirming
previous observations that CTGF is a stretch responsive
gene17 (Figure 8a and b). TGF-b1 did not significantly alter
E-cadherin protein levels in either CTRL or HYPO medium
(Figure 8a and c).
DISCUSSION
A study by Iwano et al.6 using mice with a LacZ reporter
expression system under proximal tubule-specific g-glutamyl
transferase promoter control is the most frequently cited as
providing functional evidence for EMT in UUO. Following
obstruction, 36% of activated (fibroblast-specific protein-1
positive) fibroblasts in the interstitium appeared to derive
from epithelium (fibroblast-specific protein-1 positive and
LacZ positive), suggesting a large contribution of proximal
tubular EMT Recent reports suggesting that fibroblast-
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Figure 3 | Acute and chronic changes in E-cadherin mRNA
following UUO. Real-time RT-PCR analysis of E-cadherin mRNA
expression in renal extracts of NL and L kidneys at 3 and 6 h and 3
and 10 days post-UUO. An average value ±s.d for 18S normalized
E-cadherin mRNA level was determined from six 3 h NL kidneys
and used a calibrator against that expression levels in all other
groups were compared. Fold change versus 3 h NL was compared
for each individual group sample using the formula 2^-dCT
(dCT¼ observed CT value–mean 3 h NL CT value), n¼ 6 for 3 h and
6 h NL and L. n¼ 6 ,*Po0.05, 3 h NL versus 3 h L, #Po0.001 versus
3 h NL.
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Figure 4 | Upregulation of E-cadherin protein in chronic stages
of UUO. (a) Western blotting image of E-cadherin protein
expression in total renal extracts from NL and L kidneys at 3 and
10 days post-UUO. (b) Densitometric quantification of E-cadherin
protein expression in NL and L kidneys at 3 and 10 days post-UUO.
n¼ 3 animals per group, *Po0.05 versus time matched NL kidney.
(c) Distinct band size profiles detected by long exposures of
membranes containing total renal extracts from NL and L kidneys
at 3 and 10 days post-UUO, incubated with a cytoplasmic
C-terminal targeted anti-E-cadherin antibody.
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specific protein-1 is expressed in monocytic and lymphocytic
cells invading the interstitium in renal injury may question
the conclusions of this study.13 Importantly, despite wide-
spread use of E-cadherin loss as a marker of renal EMT, the
study by Iwano et al.6 did not correlate a loss of epithelial
markers with reported EMT.
Yang and Liu18 presented Western blot analysis
showing a sudden and dramatic disappearance in renal
E-cadherin expression between 3 and 7 days after
UUO in mice. Immunohistochemical analysis of E-cadherin
expression in this study appears to show it occurring
in the proximal tubule of sham-operated mice, at
odds with the localization described herein and by
others19,20 and to be completely lost by 7 days
post-UUO.
Various authors suggest that the antifibrotic effects of their
respective novel therapeutic treatments in UUO might be
associated with an inhibition of EMT coincident with
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Figure 6 | Cyclic mechanical stretch of tubular cells relevant to early stages of UUO does not affect E-cadherin or TGF-b1 mRNA
levels. Over an 18 h period, the expression of E-cadherin mRNA was compared in confluent cultures of the human renal proximal epithelial
line (HRPE) line seeded on collagen IV-coated six-well plates. (a) Cells were either (1) maintained in normotension (non-stretch), (2) exposed
to 18 h of stretch oscillating between 1 and 1.5% elongation (10–15 mm Hg)–—physiological stretch), or (3) 18 h of differential stretch as
follows (1–1.5% elongation 3 h, 3–3.5% elongation (30–35 mm Hg) for 3 h, and finally 2.5–2.575% elongation (25–25.5 mm Hg) for the
remaining 12 h—pathological stertch. (b) 18S rRNA normalized threshold cycle numbers (CT) for E-cadherin and TGF-b1 mRNA were then
compared between groups. n¼ 3 independent experiments per group.
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Figure 5 | Immunohistochemical detection of E-cadherin in the kidneys of rats following UUO. E-cadherin localization studies were
carried out on 4 mm coronal sections of rat kidney at 3 and 10 days post-UUO. Images are at  20 original magnification and are
representative of n¼ 3 per group. At both 3 and 10 days, expression of E-cadherin in NL kidneys was found in the basolateral aspects of
distal tubular cells of the cortex (a, c) and throughout the epithelium of the thick and thin segments of the loop of Henle and the collecting
system of the medulla (b, d). Expression of E-cadherin in the L kidney at 3 and 10 days post-UUO, followed a similar localization in the cortex
and medulla as that found in time matched in NL kidneys (e–h). However, staining was found to be more pronounced in the lateral cell
junctions of dilated tubules (red arrow in e) of the cortex and medulla. By 10 days post-UUO, evidence of such a pattern of expression was
sustained in grossly dilated medullary segments surrounded by expanded, fibrotic interstitium (black arrow in h).
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preservation of E-cadherin levels in the L kidney.9–12 Potential
differences with our model include that with the exception of
Mao et al.,11 these studies were all in mice. Also with the
exception of Liu et al.,12 none of these studies included
mRNA data, although in Liu et al.12 GAPDH was used to
normalize results, inappropriate given that it is upregulated
by hypoxia and the L kidney has been shown to suffer
progressive hypoxia.21,22 Lastly, in none of the above was a
comparison of L versus NL kidney.
Although the NL kidney undergoes adaptive functional
changes in the time course of our studies, it shows no acute
injury or fibrotic changes precluding its use as a control in
studies of fibrosis in UUO and has been used as such
previously in articles cited herein.6,22 We showed no
significant time-dependent alteration in E-cadherin expres-
sion in the NL kidney. Were a decrease in L kidney
E-cadherin versus sham kidneys to exist in our model, this
would leave the NL kidney with an even more marked
decrease. As no fibrosis occurs in the NL kidney this would
question whether E-cadherin loss was linked to the develop-
ment of fibrosis.
Although we found consistent upregulation of full-length
E-cadherin in the L kidney, indicating functionality, we also
observed increased generation of E-cadherin fragments. The
approximately 30 kDa C-terminal fragment detected in L
kidneys may reflect cells undergoing apoptosis, as caspase-3
has been demonstrated to cleave the C terminus to leave a
fragment of this size.23 Additionally, matrix metalloprotei-
nase-mediated extracellular cleavage of an 80 kDa fragment
has been described in ischemic renal tubular cell cultures,
which would leave a C-terminal fragment of 40 kDa
detectable.24 The 100 kDa fragment detected could be
indicative of loss of a 20 kDa fragment from the extracellular
N terminus. Calpain activity has been demonstrated to
generate a cytosolic 100 kDa fragment in prostate and
mammary epithelial cell lines.25 We acknowledge that in
spite of gene upregulation of E-cadherin in UUO, a number
of stimuli present in the L kidney might synergize to oppose
correct function of the protein.
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Figure 7 | Hypotonic stretch of tubular cell cultures increases
E-cadherin mRNA and protein expression. LLCPK-1 cells were
exposed for 24 h to standard culture medium diluted 1:1 with
distilled water to produce a medium of 155 mOsm (HYPO),
thereby inducing cell swelling and hypotonic stretch. The effect of
this on E-cadherin expression was assessed by comparison with
cells exposed to standard medium (300 mOsm, CTRL) and isotonic
diluted medium (289 mOsm, ISO) generated by diluting culture
medium 1:1 with 150 mM NaCl solution. (a) Real-time RT-PCR
analysis of E-cadherin expression in LLCPK-1 cells following 24 h
exposure to CTRL, HYPO, or ISO medium. Fold changes in HYPO
and ISO groups were calculated versus CTRL as the calibrator .
n¼ 3 per group with three wells of a six-well plate pooled per
treatment during each round *Po0.05 CTRL versus HYPO.
(b) Western blotting of E-cadherin expression in LLCPK-1 cells
following 24 h exposure to CTRL, HYPO, or ISO medium.
(c) Densitometric quantification of LLCPK-1 E-cadherin protein
expression, values were compared by one-way ANOVA, data are
mean arbitary percentage densitometric units±s.d. n¼ 4 per
group, from four independent experiments, *Po0.05 CTRL versus
HYPO.
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Figure 8 | Hypotonic stretch induction of E-cadherin is
unaffected by TGF-b1 coincubation. LLCPK-1 cells were
incubated with or without the pro-EMT growth factor TGF-b1
(3 ng/ml) during a 24 h exposure of cells to CTRL or HYPO
medium. (a) Western blot analysis of CTGF and E-cadherin
expression. (b) Densitometric quantification of the CTGF and (c)
E-cadherin protein expression in LLCPK-1 cells exposed to CTRL or
HYPO medium in the presence or absence of TGF-b1 (3 ng/ml).
Values were compared by one-way ANOVA, data are mean
arbitary percentage densitometric units ±s.d. n¼ 3 per group
from three independent experiments *Po0.01 versus CTRL.
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We sought an explanation for our data in the specific stress
stimuli of the UUO model. In Figures 1 and 2, we reassert the
fact that tubular dilatation, inflammation, and fibrosis are
progressive, linked events in obstructive nephropathy. Acute,
cyclical retrograde pressure transfer, and progressive pooling of
urine represent tubular insults specific to UUO. Early after the
onset of UUO, intratubular pressure are elevated threefold, and
this reduces to an intermediate level by 24 h.26 Sustained
increases in tubular pressure are likely in this model, given that
urine continues to pool and studies in dogs show a sevenfold
increase in aperistaltic intrapelvic pressure following 4 weeks of
obstruction.27 When we simulated a UUO pressure environ-
ment in RHPTEC cells, we observed no change in E-cadherin
expression, interesting given E-cadherin mRNA increased after
3 h in vivo, a time correlating to maximal intratubular pressure
generation. In spite of this negative result, there does exist
evidence in the literature regarding a role for cadherins in
resistance to mechanical stretch. For example, N-cadherin
mediates mechanical stretch signaling in fibroblasts,28,29
whereas hydrostatic pressure protects endothelial monolayer
integrity via VE-cadherin.30
In agreement with other authors, we recently showed that
pooled urine in UUO is markedly hypotonic.31 The effect of
this on tubular cell behavior in UUO remains largely
unexplored. Hypothetically, it could be proposed that the
hypotonic nature of pooled urine in UUO might potentially
induce hypotonic cell swelling. E-cadherin is upregulated by
hypotonic stretch in keratinocytes29 and we observed that
mechanical stretch of LLCPK-1 cells as induced by exposure
to hypotonic medium induced increases in E-cadherin
expression and induction of CTGF. CTGF has previously
been shown to be upregulated in UUO,32 stretch sensitive,17
and is suggested to be a component of renal EMT.33 We
demonstrate that CTGF and E-cadherin can be simulta-
neously upregulated in response to hypotonic stretch,
suggesting that profibrotic activation of tubular cells might
not require a ‘classical’ EMT process.
Stretch-induced E-cadherin expression is not prevented by
coincubation with TGF-b1, a key profibrotic cytokine in
UUO and proposed (including in reports by ourselves) to be
the central regulator of renal tubular EMT.15 The ability of
TGF-b1 to induce EMT declines with increasing confluence
and epithelial integrity,34 validating our findings in the
compact LLCPK-1 line.
Interestingly, TGF-b1 adenoviral vector induced perito-
neal fibrosis, showed E-cadherin expression was actually
modestly increased during fibrotic disease evolution, empha-
sizing that active TGF-b1 does not always induce a reduction
in E-cadherin expression.
In summary, the major message that we would like to
transmit in this paper is that E-cadherin expression in our
model of UUO is clearly and convincingly upregulated in the
L kidney. The fact that this phenomenon is observable is
notable given that it is occurring in the context of ongoing
tubular atrophy and is therefore likely to derive from
adaptation in remnant tubules.
We believe that these findings are strongly supported by
recent reports by Picard et al.14 that fail to observe at electron
microscope level any ultrastructural changes indicative of
EMT in UUO.
Although our model of cyclic stretch failed to show an
increase in E-cadherin, the fact that E-cadherin was increased
early after UUO when high pressure predominates, and at
later time points when dilatation of tubular zones expressing
E-cadherin is evident, is sufficient to not rule out the
possibility of a pressure effect. Whether hypotonic stretch
induced E-cadherin is of relevance other than as a
demonstration of a stretch response remains unclear.
Although our finding may contradict those of several
respected researchers in the area, we are conscious that they
do not rule out a role for EMT in renal fibrosis per se. Rather
they add to the debate by specifically challenging the
appropriateness of E-cadherin expression as a marker of
EMT, and therefore fibrosis in UUO.
MATERIALS AND METHODS
Reagents
Unless specified here, all reagents were from Sigma-Aldrich (Dublin,
Ireland).
Real-time RT-PCR primers for rat and human E-cadherin, TGF-
b1, and the 18S rRNA were supplied as assays by Applied Biosystems
(UK). Porcine primer and probe sets were prepared for E-cadherin:
forward, GTGTCCCCACCAGCTAGCA; reverse, TGGTTAGTACCC
GAAGCACAGA; Probe, CAGACATCAACAAAAGCAGGCACTTG
GG, Dharmacon (UK).
Primary antibodies used were mouse anti-human Hsp47
(Stressgen SPA-470F, Cambridge Bioscience, UK), goat anti-human
CTGF (sc-14940, Santa Cruz Biotechnology, Santa Cruz, USA), and
mouse anti-human E-cadherin (61081 BD Biosciences, UK).
Peroxidase-conjugated secondary antibodies were anti-mouse
HRP-IgG (7056 Cell Signalling, Danvers, USA) and donkey anti-
goat HRP-IgG (sc-2020 Santa Cruz Biotechnology). Recombinant
TGF-b1 was from R&D systems (Abingdon, England).
RHPTECs immortalized using ectopic expression of the human
telomerase reverse transcriptase gene were kindly provided by Dr
Regina Voglauer (University of Natural Resources and Applied Life
Sciences, Vienna). LLCPK-1 cells were the gift of Professor Michael
Ryan (University College Dublin).
Animals and treatments
Male Wistar rats weighing 200–250 g (2 months) were reared at The
University College Dublin Biomedical Facility (24 h, 3 and 10 days
experiments) and Servicio Experimental Animal at The University of
Salamanca, Spain (3 and 6 h experiments). Rats were housed within
a temperature/humidity controlled room on a 12 h light/ dark cycle.
The 3 and 10 days experiments were carried out under a
Department of Health and Children license (B100/3611) Acute
studies adhered to Conseil de l0Europe and Spanish Government
regulations. All Animal usage was in accordance with the ‘NIH
Guide for Care and Use of Laboratory Animals’.
Surgery
Following laparotomy under isoflurane anesthesia, the left ureter
was identified and excess fat removed using small forceps. The ureter
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was occluded in two places 2 cm distal to the ureteropelvic junction
using 5/0 silk ligatures. Results from a total of 24 experimental
animals are presented. Specific replication for each assay is indicated
in adjoining figure legends.
Histological and immunohistochemical studies
Perfused kidneys were fixed overnight in 10% non-buffered
formalin, embedded in paraffin, and 4 mm were sections cut and
mounted. Rehydrated sections were incubated with hematoxylin and
eosin or for assessment of fibrosis, incubated sequentially in Bouin’s
Fixative, Wiegert’s iron hematoxylin, and Gomori’s trichrome stain
(all polysciences Europe GmbH), and 0.5% acetic acid. Sections
were then dehydrated, mounted, and coverslipped.
E-cadherin immunohistochemistry was carried out using the
Vectastain Universal ABC kit (Vector Laboratories, UK) with a 1 h
room temperature incubation of the primary antibody at 1/200 in
0.2% bovine serum albumin in phosphate-buffered saline. Sections
diaminobenzidine developed, counterstained with hematoxylin,
dehydrated, mounted, and coverslipped.
Histological and immunohistochemical images were captured
using the Aperio ScanScope CS system with image processing in
Amperio Image Scope (Aperio, USA)
Quantification of distal tubular luminal area
Coronal hematoxylin and eosin sections of 24 h, 3- and 10-day NL
and L kidneys were viewed at  20 in Image Scope (Aperio) and
distal tubules in transverse section identified by their relative
sparsity and bulging nuclei in cortical areas. The circumferences of
10 distal tubular segments per sample were highlighted and the
software calculated the area enclosed in mM2. Mean areas per sample
were calculated and used to generate group means in replicated
samples.
RHPTEC cells and LLCPK-1 cells
RHPTEC and LLCPK-1 were used in this study on the basis of their
high epithelial resistance and expression and appropriate localiza-
tion of junctional proteins including E-cadherin. RHPTEC cells
were cultured in Dulbecco’s modified Eagle’s-Hams F-12 medium
containing the following supplements: 2 mM glutamine, 1%
penicillin–streptomycin, epidermal growth factor (10 ng/ml), hydro-
cortisone (36 ng/ml), insulin–transferrin–sodium selenite (5 mg/ml,
5 mg/ml, 5 ng/ml), ascorbic acid (3.5 mg/ml), HEPES (10 mM),
prostaglandin E1 (25 ng/ml), and tridothyronine (3 pg/ml).
LLCPK-1 cells were cultured in Dulbecco’s modified Eagle’s-
Hams F-12 medium containing 10% fetal bovine serum, 2 mM
glutamine, and 1% penicillin–streptomycin.
Simulating early mechanical stretch changes in RHPTEC cells
Stretch experiments in the context of UUO, frequently use frac12;
sine 5 s stretch/5 s relax cycles oscillating between 0 and 10 or 20%
elongation.7,35 However, a 1% elongation in The Flexcell 4000T
system is equivalent to a vacuum pressure of 1 kPa, and this in turns
translates as 7.7 mm Hg, therefore 20% stretch results in cells being
exposed to a vacuum of 154 mm Hg (7.7 20) during cycling. Acute
elevations in tubular pressure in ureteral obstruction in the rat are
reported to extend from 10 mm Hg to a maximum of 30 mm Hg
(equivalent to 1 and 3% elongation) by 3 h post-obstruction and
then fall to an intermediate level by 24 h.26 We therefore chose to
replicate our model on a 1–3% oscillated pressure in single phase
spikes with a frequency of 0.15 Hz reflecting renal pelvic
contractility.27
Stretch protocol
RHPTEC cells were confluence on collagen IV-coated Bioflex plate
(Flexcell Int and then maintained in (1) normotension for 18 h, (2)
exposed to 18 h of stretch oscillating between 1 and 1.5% elongation
(10–15 mm Hg)–Physiological stretch, or (3) 18 h of differential
stretch as follows (1–1.5% elongation 3 h, 3–3.5% elongation
(30–35 mm Hg) for 3 h, and finally 2.5–2.575% elongation
(25–25.5 mm Hg) for the remaining 12 h—Pathological stretch.
Hypotonic stretching of LLCPK-1 cells
LLCPK-1 cells were grown to confluence in six-well plates then
serum starved in defined medium containing: 5 mg/ml insulin, 5 mg/
ml transferrin, 5 ng/ml sodium selenite, 36 ng/ml hydrocortisone for
24 h. At this time point, cells were incubated for 24 h in either
normal defined medium (CTRL, 300 mOsm), defined medium
diluted 1:1 with distilled water (HYPO, 150 mOsm), or in defined
medium diluted 1:1 with 150 mM (300 mOsm) NaCl (ISO,
289 mOsm). In some cases cells were coincubated with TGF-b1
(3 ng/ml), a dose reported to induce EMT, including loss of E-
cadherin expression in other renal cell lines.2
RNA extraction/cDNA synthesis/real-time RT-PCR
Total RNA was extracted using Tri-Reagent and cDNA generated by
reverse transcription using random hexamers following DNase
digestion (Invitrogen, Ireland). Transcript levels were determined by
real-time TaqMan PCR using a PerkinElmer 7700 analyzer.
Cycling conditions were as follows: step (1), 2 min at 50 1C; step (2),
10 min at 95 1C; step (3), 15 s at 95 1C; step (4), 1 min at 60 1C; step (5),
repeat from step 3 for an additional 39 times. Probes were labeled with
50-FAM and with 30-TAMRA as quencher, with the exception of the
ribosomal probe, which was labeled with 50-VIC to facilitate multi-
plexing. For analysis of expression in the rat kidney, 18S normalized CT
values for 3 h NL were calculated, averaged, and assigned a value of
1±s.d (calibrator). In hypotonicity experiments, control cultures were
likewise assigned a value of one individual results for all other samples
were expressed as fold changes versus the calibrator.
Protein extraction
Powdered renal tissue (200 mg) was homogenized in 2 ml tissue lysis
buffer (140 mM NaCl, 10 mM EDTA, 10% glycerol, 1% NP40, 20 mM
Tris (pH 8.0), 10 mM phenylmethylsulphonyl fluoride, 1 mM
leupeptin, 1 mM aprotinin, and 2 mM pepstatin) using a polytron
homogenizer. Homegenates were lysed on ice for 30 min and
centrifuged (13,000 r.p.m at 4 1C).
Cellular protein was extracted by scraping phosphate-buffered
saline washed monolayers into 200 ml of NP-40 protein lysis buffer
(0.5% NP-40, Tris 10 mM (pH 8.0), 60 mM KCl, 1 mM EDTA (pH
8.0), 1 mM DTT, 10 mM phenylmethylsulphonyl fluoride, 10 ml/ml
phosphotase inhibitor cocktail, 1 mM leupeptin, 1 mM sodium
orthovanadate, 1 mM aprotinin, and 2 mM pepstatin). The cell lysate
was centrifuged (13,000 r.p.m./10 min/4 1C). Supernatant protein
concentrations were determined using a modified Lowry assay kit
(Bio-Rad, UK).
Western blotting
Protein samples (50 mg) were resolved in SDS polyacrylamide
gels for 80 min at 140 V, then electrophoretically transferred
to an inmobilon-P membrane, (Millipore, UK) at 100 V for
80 min.
Membranes were incubated in blocking buffer (5% bovine serum
albumin or 5% nonfat milk) in TTBS (Tris-buffered saline (pH
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7.4)þ 0.1% Tween20) for 1 h at room temperature, then n primary
antibody (1:1000) for a further 1 h in antibody incubation buffer
(3% bovine serum albumin or 5% nonfat milk) in TTBS. After
washing for 5 5 min in TTBS buffer, membranes were incubated
for 1 h at room temperature with horseradish peroxidase-conjugated
anti-mouse or anti-goat IgG at a dilution of 1:5000). Blots were
further washed developed on Super RX autoradiograhic film
(Fujfilm, Japan) using ECL (Roche, Ireland). Scanning densitometry
of developed blots was carried out using UN-SCAN-IT (Silk
Scientific Corp., Orem, USA).
Although b-actin was unchanged in in vitro, we found a large
upregulation of b-actin protein in the L kidney. This coincided with
increases in b-actin mRNA and apparent localization of increases to
the inflammatory infiltrate (Supplementary Data). Recent similar
reports have been made in the UUO model including another
commonly used loading control, a-tubulin.36 Membranes were
therefore stained with coommasie blue to check equal loading and
transfer.
Statistical analyses
Results are expressed as mean±s.d. and analyzed by one-way
analysis of variance with Bonferroni post hoc testing using SPSS
version 12.0.1 for windows (SPSS Inc., USA).
Statistical significance was set at Po0.05. When significance
values were less than 0.001 (99.9% confidence limits), results are
reported as Po0.001.
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